• print
  • mail
  • Home
  • Reimbursement Connection®
  • Enbrel®
    (etanercept)

  • Overview
  • Amgen™ Oncology Assistance
  • Aranesp®
    (darbepoetin alfa)
  • Neulasta®
    (pegfilgrastim)
  • NEUPOGEN®
    (Filgrastim)
  • Nplate®
    (romiplostim)
  • EPOGEN®
    (Epoetin alfa)
  • Sensipar®
    (cinacalcet)
  • Enbrel®
    (etanercept)
  • Vectibix®
    (panitumumab)
Enbrel® (etanercept) Reimbursement
Enbrel is manufactured by Immunex Corporation and Marketed by Amgen and Wyeth Pharmaceuticals. For insurance support a dedicated ENBREL liaison is available to health care professionals, medical billing staff, and patients who have questions about insurance coverage and reimbursement for ENBREL.

For further information please visit the Enbrel product site.

 

 

 

 

 

 


  • Related Links
  • Amgen Medical Information Connection™
footer